Hygeia Healthcare Holdings Full Year 2023 Earnings: Misses Expectations

Hygeia Healthcare Holdings (HKG:6078) Full Year 2023 Results

Key Financial Results

• Revenue: CN¥4.08b (up 28% from FY 2022).
• Net income: CN¥682.9m (up 43% from FY 2022).
• Profit margin: 17% (up from 15% in FY 2022). The increase in margin was driven by higher revenue.
• EPS: CN¥1.08 (up from CN¥0.77 in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Hygeia Healthcare Holdings Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 2.4%. Earnings per share (EPS) also missed analyst estimates by 7.5%.

The primary driver behind last 12 months revenue was the Hospital Business segment contributing a total revenue of CN¥3.89b (95% of total revenue). Notably, cost of sales worth CN¥2.81b amounted to 69% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to CN¥359.7m (62% of total expenses). Explore how 6078's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Hong Kong.

Performance of the Hong Kong Healthcare industry.

The company's shares are up 14% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of Hygeia Healthcare Holdings' balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.